Pablo A. Scacchi Bernasconi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pablo A. Scacchi Bernasconi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Daniel P. Cardinali
Pontificia Universidad Católica Argentina
2 shared publications - Ana Isabel Esquifino
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28003 Madrid, Spain
1 shared publication - Carlos F. Reyes Toso
Department of Physiology, Faculty of Medicine, University of Buenos Aires, 1121 Buenos Aires, Argentina
1 shared publication Maria J. Rios-Lugo
1 shared publication- Pablo Scacchi
Department of Teaching and Research, Faculty of Medical Sciences, Pontificia Universidad Católica Argentina, 1107 Buenos Aires, Argentina
1 shared publication Pilar Cano
1 shared publication
Latest Publications
- Open Access
- 25 January 2013
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (2) , 2502-2514
Melatonin May Curtail the Metabolic Syndrome: Studies on Initial and Fully Established Fructose-Induced Metabolic Syndrome in Rats
To examine the effect of melatonin given to rats simultaneously with fructose on initial and fully developed metabolic syndrome, male Wistar rats had free access to chow and 5% or 10% fructose drinking solution for 8 weeks. As compared to controls, systolic blood pressure augmented significantly under both treatments whereas excessive body weight was seen in rats receiving the 10% fructose only. Rats drinking 5% fructose showed a greater tolerance to a glucose load while rats having access to a 10% fructose drinking solution exhibited the expected impaired glucose tolerance found in the metabolic syndrome. Circulating triglyceride and low density lipoproteins-cholesterol (LDL-c) concentration augmented significantly in rats showing a fully developed metabolic syndrome only, while high blood cholesterol levels were found at both stages examined. Melatonin (25 μg/mL drinking solution) counteracted the changes in body weight and systolic blood pressure found in rats administered with fructose. Melatonin decreased the abnormal hyperglycemia seen after a glucose load in 10% fructose-treated rats but it did not modify the greater tolerance to glucose observed in animals drinking 5% fructose. Melatonin also counteracted the changes in plasma LDL-c, triglyceride and cholesterol levels and decreased plasma uric acid levels. The results underline a possible therapeutical role of melatonin in the metabolic syndrome, both at initial and established phases.
- 25 January 2013
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (2) , 2502-2514
Open AccessMelatonin May Curtail the Metabolic Syndrome: Studies on Initial and Fully Established Fructose-Induced Metabolic Syndrome in Rats
To examine the effect of melatonin given to rats simultaneously with fructose on initial and fully developed metabolic syndrome, male Wistar rats had free access to chow and 5% or 10% fructose drinking solution for 8 weeks. As compared to controls, systolic blood pressure augmented significantly under both treatments whereas excessive body weight was seen in rats receiving the 10% fructose only. Rats drinking 5% fructose showed a greater tolerance to a glucose load while rats having access to a 10% fructose drinking solution exhibited the expected impaired glucose tolerance found in the metabolic syndrome. Circulating triglyceride and low density lipoproteins-cholesterol (LDL-c) concentration augmented significantly in rats showing a fully developed metabolic syndrome only, while high blood cholesterol levels were found at both stages examined. Melatonin (25 μg/mL drinking solution) counteracted the changes in body weight and systolic blood pressure found in rats administered with fructose. Melatonin decreased the abnormal hyperglycemia seen after a glucose load in 10% fructose-treated rats but it did not modify the greater tolerance to glucose observed in animals drinking 5% fructose. Melatonin also counteracted the changes in plasma LDL-c, triglyceride and cholesterol levels and decreased plasma uric acid levels. The results underline a possible therapeutical role of melatonin in the metabolic syndrome, both at initial and established phases.
- 6 July 2010
- Published by Bentham Science Publishers Ltd. in The Open Obesity Journal
- Vol. 2 (1) , 1-9
Effect of a High-Fat Diet on 24-Hour Pattern in Expression of Prolactin and Redox Pathway Enzymes in the Rat Adenohypophysis~!2009-06-24~!2009-10-09~!2010-06-09~!
Effect of a High-Fat Diet on 24-Hour Pattern in Expression of Prolactin and Redox Pathway Enzymes in the Rat Adenohypophysis
- 6 July 2010
- Published by Bentham Science Publishers Ltd. in The Open Obesity Journal
- Vol. 2 (1) , 1-9
Effect of a High-Fat Diet on 24-Hour Pattern in Expression of Prolactin and Redox Pathway Enzymes in the Rat Adenohypophysis~!2009-06-24~!2009-10-09~!2010-06-09~!
Effect of a High-Fat Diet on 24-Hour Pattern in Expression of Prolactin and Redox Pathway Enzymes in the Rat Adenohypophysis